{"id":5960,"date":"2026-04-01T09:15:11","date_gmt":"2026-04-01T09:15:11","guid":{"rendered":"https:\/\/regenerated.health\/menopause-guide-2\/"},"modified":"2026-07-28T10:03:59","modified_gmt":"2026-07-28T10:03:59","slug":"menopause-guide","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/menopause-guide\/","title":{"rendered":"Menopause: A Complete Evidence-Based Guide to Stages, Symptoms, and Treatments"},"content":{"rendered":"<div style=\"background:#f0f7f4;border-left:4px solid #2e7d5e;padding:20px 24px;margin-bottom:32px;border-radius:6px;\">\n<h3 style=\"margin-top:0;color:#2e7d5e;\">At a Glance<\/h3>\n<ul style=\"margin-bottom:0;\">\n<li>Menopause is a natural biological transition, not a disease. It is officially reached after 12 consecutive months without a menstrual period.<\/li>\n<li>The average age of menopause in the U.S. is 51, but perimenopause can begin in the early 40s or even late 30s.<\/li>\n<li>Declining estrogen, progesterone, and testosterone drive most symptoms, from hot flashes to brain fog to bone loss.<\/li>\n<li>Hormone replacement therapy (HRT) remains the most effective treatment for vasomotor symptoms and has a favorable risk profile when started within 10 years of menopause onset.<\/li>\n<li>Lifestyle interventions, targeted supplements, and integrative therapies can meaningfully reduce symptom burden.<\/li>\n<li>Menopause raises long-term risks for osteoporosis and cardiovascular disease, making proactive screening important.<\/li>\n<\/ul>\n<\/div>\n<h2>What Is Menopause, Exactly?<\/h2>\n<p>Menopause is the point in a woman&#8217;s life when menstruation stops permanently. It signals the end of reproductive capacity, driven by the ovaries gradually producing less estrogen and progesterone. While popular culture sometimes treats it as a sudden event, menopause is really the midpoint of a transition that can span a decade or more.<\/p>\n<p>The medical definition is precise: menopause is confirmed after 12 consecutive months without a menstrual period, in the absence of other causes like surgery, medication, or illness. Everything leading up to that point is perimenopause; everything after is postmenopause <sup>[1]<\/sup>.<\/p>\n<p>About 1.3 million women in the United States reach menopause each year. Globally, more than a billion women will be postmenopausal by 2025 <sup>[2]<\/sup>. Despite these numbers, menopause has been historically under-researched and under-discussed in clinical medicine. That is changing, but slowly.<\/p>\n<h2>The Three Stages of Menopause<\/h2>\n<h3>Perimenopause: The Long Runway<\/h3>\n<p>Perimenopause typically begins in a woman&#8217;s mid-40s, though it can start in the late 30s. This phase lasts anywhere from 2 to 10 years. During perimenopause, hormone levels do not simply decline in a straight line. Instead, estrogen and progesterone fluctuate unpredictably, sometimes spiking higher than premenopausal levels before dropping sharply.<\/p>\n<p>These hormonal swings explain why perimenopausal symptoms can feel chaotic. You might have a perfectly normal cycle one month, skip the next two, then experience heavy bleeding. Sleep disruption, mood swings, and the onset of hot flashes are common during this stage. Many women do not realize they are in perimenopause because their periods have not stopped yet <sup>[3]<\/sup>.<\/p>\n<p>The Stages of Reproductive Aging Workshop (STRAW+10) classification system divides perimenopause into early and late stages. In early perimenopause, cycle length varies by more than 7 days from your normal pattern. In late perimenopause, you begin skipping periods entirely, with gaps of 60 days or more between cycles. Recognizing which stage you are in can help set expectations and guide treatment decisions.<\/p>\n<h3>Menopause: The Marker<\/h3>\n<p>Menopause itself is a single point in time, defined retrospectively. You only know you have reached it after a full year without a period. The average age is 51 in Western countries, but the normal range spans from 45 to 55. Reaching menopause before age 40 is classified as premature ovarian insufficiency, which carries distinct health considerations.<\/p>\n<h3>Postmenopause: The New Baseline<\/h3>\n<p>Postmenopause describes the rest of your life after menopause. Hormone levels stabilize at their new, lower baseline. Many acute symptoms like hot flashes diminish over time, though some women experience them for a decade or longer. The more pressing concerns in postmenopause are the long-term effects of estrogen deficiency on bone density, cardiovascular health, and cognitive function <sup>[4]<\/sup>.<\/p>\n<h2>What Happens to Your Hormones<\/h2>\n<p>Three hormones drive most of the changes you feel during the menopause transition.<\/p>\n<p><strong>Estrogen (estradiol)<\/strong> is the primary female sex hormone. It does far more than regulate reproduction. Estrogen receptors exist in your brain, bones, heart, skin, and joints. When estrogen declines, every one of those systems feels the effect. Estradiol levels can drop by 85-90% from premenopausal peak to postmenopausal baseline <sup>[5]<\/sup>.<\/p>\n<p><strong>Progesterone<\/strong> is the first hormone to decline, often years before estrogen drops significantly. During perimenopause, anovulatory cycles (cycles where no egg is released) become more frequent. Without ovulation, the corpus luteum does not form, and progesterone is not produced. This creates a state of relative estrogen dominance that can cause heavy periods, breast tenderness, and irritability.<\/p>\n<p><strong>Testosterone<\/strong> declines gradually, dropping about 50% between your 20s and your mid-40s. This decline is not specific to menopause but accelerates during the transition. Lower testosterone can affect libido, muscle mass, energy, and mood <sup>[6]<\/sup>.<\/p>\n<h2>Common Symptoms and How They Show Up<\/h2>\n<h3>Vasomotor Symptoms: Hot Flashes and Night Sweats<\/h3>\n<p>Hot flashes are the hallmark of menopause. They affect up to 80% of women during the transition. A hot flash is a sudden sensation of intense heat, usually starting in the chest and rising to the face and neck. It can last 30 seconds to 5 minutes and may be followed by chills and sweating. Night sweats are simply hot flashes that occur during sleep, and they can severely disrupt rest <sup>[7]<\/sup>.<\/p>\n<p>The mechanism appears to involve a narrowing of the thermoneutral zone in the hypothalamus, driven by declining estrogen and changes in neurokinin B signaling. Your body becomes hypersensitive to small temperature changes, triggering inappropriate heat-dissipation responses.<\/p>\n<p>For most women, hot flashes last 4 to 7 years. But research from the Study of Women&#8217;s Health Across the Nation (SWAN) found that about a third of women still experience them more than 10 years after menopause. Women who begin having hot flashes in early perimenopause tend to have them for longer than those whose hot flashes start closer to the final menstrual period.<\/p>\n<h3>Sleep Disruption<\/h3>\n<p>Sleep problems affect 40-60% of menopausal women. Night sweats are one cause, but hormonal shifts also directly affect sleep architecture. Declining progesterone, which has natural sedative properties, contributes to difficulty falling and staying asleep. Poor sleep then cascades into fatigue, mood changes, and impaired concentration <sup>[8]<\/sup>.<\/p>\n<h3>Mood Changes and Brain Fog<\/h3>\n<p>Estrogen modulates serotonin, dopamine, and norepinephrine, all neurotransmitters tied to mood and cognition. During perimenopause, the risk of new-onset depression roughly doubles. Anxiety, irritability, and difficulty concentrating are common complaints. Many women describe a mental cloudiness or word-finding difficulty that is genuinely distressing <sup>[9]<\/sup>.<\/p>\n<p>It is important to note: this cognitive &#8220;fog&#8221; is typically not a sign of dementia. Studies show that the subjective cognitive complaints of perimenopause generally do not correlate with objective cognitive decline and tend to improve in postmenopause.<\/p>\n<h3>Vaginal and Urogenital Changes<\/h3>\n<p>Declining estrogen thins the vaginal epithelium, reduces lubrication, and alters the vaginal microbiome. This can cause dryness, irritation, painful intercourse, and increased susceptibility to urinary tract infections. Unlike hot flashes, these symptoms tend to worsen over time without treatment. The medical term is genitourinary syndrome of menopause (GSM) <sup>[10]<\/sup>.<\/p>\n<h3>Joint Pain and Musculoskeletal Changes<\/h3>\n<p>Estrogen has anti-inflammatory effects on joint tissue. Its decline can trigger new onset joint stiffness and pain, sometimes mistaken for early arthritis. Up to 50% of menopausal women report joint symptoms. Muscle mass also begins to decline more rapidly, partly due to lower testosterone and partly due to aging itself.<\/p>\n<h3>Weight Gain and Body Composition Shifts<\/h3>\n<p>Many women notice increased abdominal fat during the menopause transition, even without changes in diet or exercise. Hormonal shifts promote a redistribution of fat from the hips and thighs to the abdomen. This visceral fat is metabolically active and raises cardiovascular risk. Declining estrogen also affects insulin sensitivity, making weight management more difficult <sup>[11]<\/sup>.<\/p>\n<h3>Hair Thinning<\/h3>\n<p>Reduced estrogen and relative androgen excess can trigger diffuse hair thinning. Hair may become finer, grow more slowly, or shed more. Some women also notice increased facial hair due to the shifting estrogen-to-androgen ratio.<\/p>\n<h3>Heart Palpitations<\/h3>\n<p>Many women experience heart palpitations during perimenopause, a symptom that is common but often anxiety-producing. The feeling of a racing, pounding, or fluttering heart is usually benign and related to hormonal fluctuation and autonomic nervous system changes. That said, new-onset palpitations should be evaluated with an EKG and, if appropriate, a Holter monitor to rule out arrhythmia.<\/p>\n<h3>Skin Changes<\/h3>\n<p>Estrogen plays a key role in collagen production and skin hydration. After menopause, women lose approximately 30% of their skin collagen within the first five years. Skin may become thinner, drier, and more prone to wrinkling. Some women develop a sensation of crawling or itching skin, called formication, which is related to changing nerve function.<\/p>\n<h2>Diagnosis<\/h2>\n<p>In most cases, menopause is diagnosed clinically based on age, symptoms, and menstrual history. Blood tests for follicle-stimulating hormone (FSH) can support the diagnosis, but FSH fluctuates significantly during perimenopause and is not always reliable as a standalone marker.<\/p>\n<p>For women under 45 with suspected premature menopause, or for those who have had a hysterectomy without oophorectomy, hormone testing becomes more important. An FSH level above 30 mIU\/mL on two separate occasions, combined with low estradiol, supports the diagnosis <sup>[12]<\/sup>.<\/p>\n<p>Other conditions that mimic menopause symptoms, including thyroid disease, depression, and pregnancy, should be ruled out, especially in younger women.<\/p>\n<h2>Conventional Treatments<\/h2>\n<h3>Hormone Replacement Therapy (HRT\/MHT)<\/h3>\n<p>Menopausal hormone therapy remains the gold standard for treating vasomotor symptoms, and it is also effective for GSM, sleep disruption, and bone loss prevention. Modern guidelines from the North American Menopause Society (NAMS) support initiating HRT in symptomatic women under 60 or within 10 years of menopause onset, provided there are no contraindications <sup>[13]<\/sup>.<\/p>\n<p>Standard HRT involves estrogen plus a progestogen (for women with a uterus, to protect against endometrial hyperplasia). Women who have had a hysterectomy can take estrogen alone. Delivery methods include oral pills, transdermal patches, gels, sprays, and vaginal rings. Transdermal estrogen avoids the first-pass liver effect and carries a lower risk of blood clots compared to oral formulations.<\/p>\n<p>The fear around HRT that followed the Women&#8217;s Health Initiative (WHI) study in 2002 was largely based on misinterpretation of the data. The WHI studied older women (average age 63) starting hormone therapy years after menopause. Subsequent reanalysis has shown that for women who start HRT closer to menopause onset, the benefits generally outweigh the risks. The &#8220;timing hypothesis&#8221; is now well-supported: early initiation is both safer and more effective.<\/p>\n<p>Contraindications to systemic HRT include unexplained vaginal bleeding, active liver disease, a history of breast cancer, a history of blood clots or stroke, and known clotting disorders. For women with these conditions, non-hormonal options and local vaginal therapies may still be appropriate.<\/p>\n<h3>Bioidentical Hormones<\/h3>\n<p>Bioidentical hormones are chemically identical to the hormones your body produces. FDA-approved bioidentical options include estradiol patches, gels, and micronized progesterone (Prometrium). Custom-compounded bioidentical hormones are also available from compounding pharmacies, though they lack the standardized dosing and FDA oversight of manufactured products <sup>[14]<\/sup>.<\/p>\n<h3>Non-Hormonal Prescription Options<\/h3>\n<p>For women who cannot or prefer not to take hormones, several prescription alternatives exist. SSRIs and SNRIs (particularly paroxetine, venlafaxine, and escitalopram) can reduce hot flash frequency by 40-60%. Gabapentin helps with hot flashes and sleep. The newer NK3 receptor antagonist fezolinetant (Veozah) targets the thermoregulatory pathway directly and received FDA approval in 2023 <sup>[15]<\/sup>.<\/p>\n<h3>Vaginal Estrogen<\/h3>\n<p>Low-dose vaginal estrogen (creams, tablets, rings) treats GSM with minimal systemic absorption. It is considered safe even for many women with a history of breast cancer, though this should always be discussed with an oncologist. Vaginal estrogen is distinct from systemic HRT and can be used alone or alongside it.<\/p>\n<h2>Integrative and Lifestyle Approaches<\/h2>\n<h3>Exercise<\/h3>\n<p>Regular physical activity is one of the most evidence-supported interventions for menopause management. Resistance training preserves muscle mass and bone density. Cardiovascular exercise supports heart health and can modestly reduce hot flash frequency. Yoga and tai chi have shown benefits for sleep, mood, and stress reduction <sup>[16]<\/sup>.<\/p>\n<p>The general recommendation is at least 150 minutes of moderate aerobic activity per week, plus two or more sessions of resistance training.<\/p>\n<h3>Adaptogens and Herbal Supplements<\/h3>\n<p><strong>Black cohosh<\/strong> is the most studied herbal remedy for hot flashes. Some trials show modest benefit, while others do not. The North American Menopause Society considers it reasonable to try for up to 6 months for women with mild to moderate symptoms <sup>[17]<\/sup>.<\/p>\n<p><strong>Ashwagandha<\/strong> has shown promise in small trials for reducing stress, improving sleep, and supporting hormonal balance during perimenopause. It acts on the HPA axis to modulate cortisol.<\/p>\n<p><strong>Maca root<\/strong> has some evidence for improving mood and sexual function in menopausal women, though studies are limited.<\/p>\n<h3>Targeted Supplements<\/h3>\n<p><strong>Vitamin D and calcium<\/strong> are essential for bone health during and after menopause. Most experts recommend 1,000-1,200 mg of calcium daily (preferably from food) and 1,000-2,000 IU of vitamin D3.<\/p>\n<p><strong>Magnesium<\/strong> supports sleep, mood, and bone health. Many women are deficient. Magnesium glycinate and threonate are well-absorbed forms.<\/p>\n<p><strong>Omega-3 fatty acids<\/strong> may help with mood, joint pain, and cardiovascular protection.<\/p>\n<h3>Acupuncture<\/h3>\n<p>Several randomized controlled trials have found that acupuncture reduces hot flash frequency by 25-40%, comparable to some medications. It may also improve sleep quality and mood. The effect appears to be more than placebo, though the mechanism is not fully understood <sup>[18]<\/sup>.<\/p>\n<h3>Meditation and Stress Reduction<\/h3>\n<p>Mindfulness-based stress reduction (MBSR) has been shown to reduce the perceived severity of hot flashes, even if the frequency does not change dramatically. Chronic stress raises cortisol, which can worsen sleep disruption, weight gain, and mood instability. Regular meditation, breathwork, or other stress-management practices are valuable during this transition.<\/p>\n<h2>Menopause and Bone Health<\/h2>\n<p>Women lose up to 20% of their bone density in the 5-7 years following menopause, primarily due to estrogen withdrawal. This accelerated bone loss is why osteoporosis disproportionately affects postmenopausal women. A DEXA scan to measure bone mineral density is recommended for all women at age 65, or earlier if risk factors are present <sup>[19]<\/sup>.<\/p>\n<p>Prevention strategies include weight-bearing exercise, adequate calcium and vitamin D, limiting alcohol and smoking, and in some cases, HRT or prescription medications like bisphosphonates or denosumab.<\/p>\n<p>A common misconception is that osteoporosis is only a concern for very old women. In reality, the most rapid bone loss occurs in the first few years after menopause. By the time a fracture happens, significant bone has already been lost. This is why baseline bone density screening and early intervention matter so much.<\/p>\n<h2>Cardiovascular Risk After Menopause<\/h2>\n<p>Before menopause, women have a lower rate of heart disease than men of the same age. After menopause, that gap narrows significantly. Estrogen has protective effects on blood vessel function, cholesterol metabolism, and inflammation. Its loss contributes to rising LDL cholesterol, increasing arterial stiffness, and a higher risk of atherosclerosis <sup>[20]<\/sup>.<\/p>\n<p>This makes cardiovascular screening in postmenopause especially important. Monitoring blood pressure, lipid panels, fasting glucose, and inflammatory markers like hs-CRP should be part of routine care.<\/p>\n<p>Heart disease is the leading cause of death in women, killing more women each year than all cancers combined. The menopause transition is a critical window for risk assessment and prevention. Women who experience early menopause (before age 45) have a notably higher lifetime cardiovascular risk and should discuss screening and prevention strategies with their provider early.<\/p>\n<h2>Cognitive Changes and Brain Health<\/h2>\n<p>The brain is rich in estrogen receptors, particularly in the hippocampus and prefrontal cortex, areas critical for memory and executive function. During perimenopause, many women notice changes in verbal memory, attention, and processing speed. Neuroimaging studies show that the brain undergoes metabolic changes during this transition, including shifts in glucose metabolism and white matter integrity <sup>[21]<\/sup>.<\/p>\n<p>The reassuring news: for most women, cognitive function stabilizes and can even improve in postmenopause as the brain adapts to its new hormonal environment. Staying physically active, socially engaged, and mentally stimulated supports cognitive resilience.<\/p>\n<h2>Sexual Health During and After Menopause<\/h2>\n<p>Sexual function is commonly affected by menopause. Lower estrogen causes vaginal dryness and discomfort. Lower testosterone can reduce desire. Changes in body image, mood, and relationship dynamics all play a role.<\/p>\n<p>Effective treatments exist. Vaginal estrogen restores tissue health. Vaginal DHEA (prasterone) is another option. Lubricants and moisturizers provide immediate relief. For low desire, testosterone therapy (typically compounded low-dose formulations, as no FDA-approved product exists for women in the U.S.) may help. Open communication with a partner and, when needed, a sexual health counselor can make a significant difference <sup>[22]<\/sup>.<\/p>\n<h2>Premature and Surgical Menopause<\/h2>\n<p>Premature menopause (before age 40) affects about 1% of women and carries heightened risks for osteoporosis, cardiovascular disease, cognitive decline, and overall mortality. Causes include autoimmune conditions, genetic factors, chemotherapy, and surgical removal of the ovaries (bilateral oophorectomy).<\/p>\n<p>Women with premature or surgical menopause are generally advised to take HRT at least until the average age of natural menopause (51) to mitigate these risks, unless there is a strong contraindication <sup>[23]<\/sup>.<\/p>\n<p>Surgical menopause, caused by bilateral oophorectomy, is distinct from natural menopause in that it causes an abrupt and complete loss of ovarian hormones. There is no gradual decline; the drop is immediate. This often results in more severe symptoms, particularly hot flashes and mood changes. Women undergoing surgical menopause should have a detailed conversation with their surgeon about hormone therapy before the procedure, so a treatment plan is ready from day one.<\/p>\n<h2>Nutrition and Menopause<\/h2>\n<p>Your nutritional needs shift during the menopause transition. Protein requirements increase, as preserving muscle mass becomes more difficult. Most experts recommend at least 1.0 to 1.2 grams of protein per kilogram of body weight daily, with protein distributed across meals. Phytoestrogen-rich foods (like soy, flaxseed, and chickpeas) contain plant compounds that weakly bind to estrogen receptors, and population studies suggest they may modestly reduce hot flash frequency, especially in women whose diets are consistently high in these foods.<\/p>\n<p>Reducing refined carbohydrates and added sugar is particularly important during menopause. As insulin sensitivity declines, blood sugar swings can worsen mood instability, fatigue, and weight gain. A diet centered on whole foods, adequate fiber (25-30 grams daily), healthy fats, and quality protein gives your body the raw materials it needs to adapt to its new hormonal environment.<\/p>\n<p>Alcohol is worth a specific mention. Even moderate alcohol consumption can worsen hot flashes, disrupt sleep architecture, increase breast cancer risk, and accelerate bone loss. Many women find that reducing or eliminating alcohol during the transition has a noticeable impact on symptom severity.<\/p>\n<h2>When to See a Specialist<\/h2>\n<p>Consider seeking care from a menopause-trained clinician if:<\/p>\n<ul>\n<li>Your symptoms significantly impair your quality of life<\/li>\n<li>You are under 45 and experiencing menopause symptoms<\/li>\n<li>You have a history of breast cancer or blood clots and need individualized HRT guidance<\/li>\n<li>You have tried first-line treatments without adequate relief<\/li>\n<li>You are experiencing severe mood changes, anxiety, or depression<\/li>\n<li>You want a thorough evaluation of bone and cardiovascular risk<\/li>\n<\/ul>\n<p>The NAMS practitioner directory and the Menopause Society website are good places to find certified menopause practitioners.<\/p>\n<h2>The Bottom Line<\/h2>\n<p>Menopause is not a disorder to be &#8220;fixed.&#8221; It is a biological transition. But that does not mean you should suffer through it without support. Effective treatments exist across the spectrum, from hormone therapy to lifestyle changes to targeted supplements. The best approach is one tailored to your symptoms, health history, and preferences, ideally in partnership with a provider who takes menopause seriously.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How do I know I have reached menopause?<\/h3>\n<p>Menopause is officially confirmed after 12 consecutive months without a menstrual period. The average age is 51 in Western countries, with a normal range of 45 to 55. The lead-up phase, perimenopause, can begin in the early 40s or even the late 30s and lasts anywhere from 2 to 10 years.<\/p>\n<h3>Is hormone replacement therapy safe, and who is it for?<\/h3>\n<p>Modern guidelines support starting HRT in symptomatic women under 60 or within 10 years of menopause onset who have no contraindications. Transdermal estrogen carries a lower risk of blood clots than oral formulations. Systemic HRT is not advised for women with unexplained vaginal bleeding, active liver disease, a history of breast cancer, a history of blood clots or stroke, or known clotting disorders.<\/p>\n<h3>What can I do about hot flashes if I cannot or do not want to take hormones?<\/h3>\n<p>Hot flashes affect up to 80% of women during the transition. SSRIs and SNRIs reduce hot flashes by 40 to 60%, and acupuncture reduces hot flash frequency by 25 to 40%. Fezolinetant (Veozah), a non-hormonal medication, received FDA approval in 2023.<\/p>\n<h3>How long do hot flashes and other symptoms last?<\/h3>\n<p>For most women, hot flashes last 4 to 7 years, though about a third experience them for more than 10 years after menopause. Sleep problems affect 40 to 60% of menopausal women, joint symptoms affect up to 50%, and the risk of depression roughly doubles during perimenopause.<\/p>\n<h3>Does menopause affect my bones, and how can I protect them?<\/h3>\n<p>Women can lose up to 20% of their bone density in the 5 to 7 years following menopause. The guide points to at least 150 minutes of moderate aerobic activity per week plus two or more resistance training sessions, along with vitamin D at 1,000 to 2,000 IU and calcium at 1,000 to 1,200 mg daily.<\/p>\n<h3>Is the brain fog during menopause a sign of dementia?<\/h3>\n<p>The guide states that cognitive fog is typically not a sign of dementia, and that subjective cognitive complaints generally do not correlate with objective cognitive decline. It also stresses that menopause itself is not a disorder to be fixed.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"How do I know I have reached menopause?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Menopause is officially confirmed after 12 consecutive months without a menstrual period. The average age is 51 in Western countries, with a normal range of 45 to 55. The lead-up phase, perimenopause, can begin in the early 40s or even the late 30s and lasts anywhere from 2 to 10 years.\"}},{\"@type\":\"Question\",\"name\":\"Is hormone replacement therapy safe, and who is it for?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Modern guidelines support starting HRT in symptomatic women under 60 or within 10 years of menopause onset who have no contraindications. Transdermal estrogen carries a lower risk of blood clots than oral formulations. Systemic HRT is not advised for women with unexplained vaginal bleeding, active liver disease, a history of breast cancer, a history of blood clots or stroke, or known clotting disorders.\"}},{\"@type\":\"Question\",\"name\":\"What can I do about hot flashes if I cannot or do not want to take hormones?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hot flashes affect up to 80% of women during the transition. SSRIs and SNRIs reduce hot flashes by 40 to 60%, and acupuncture reduces hot flash frequency by 25 to 40%. Fezolinetant (Veozah), a non-hormonal medication, received FDA approval in 2023.\"}},{\"@type\":\"Question\",\"name\":\"How long do hot flashes and other symptoms last?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For most women, hot flashes last 4 to 7 years, though about a third experience them for more than 10 years after menopause. Sleep problems affect 40 to 60% of menopausal women, joint symptoms affect up to 50%, and the risk of depression roughly doubles during perimenopause.\"}},{\"@type\":\"Question\",\"name\":\"Does menopause affect my bones, and how can I protect them?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Women can lose up to 20% of their bone density in the 5 to 7 years following menopause. The guide points to at least 150 minutes of moderate aerobic activity per week plus two or more resistance training sessions, along with vitamin D at 1,000 to 2,000 IU and calcium at 1,000 to 1,200 mg daily.\"}},{\"@type\":\"Question\",\"name\":\"Is the brain fog during menopause a sign of dementia?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The guide states that cognitive fog is typically not a sign of dementia, and that subjective cognitive complaints generally do not correlate with objective cognitive decline. It also stresses that menopause itself is not a disorder to be fixed.\"}}]}<\/script><\/p>\n<h2>References<\/h2>\n<ol>\n<li id=\"ref-1\">Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10. <em>J Clin Endocrinol Metab<\/em>. 2012;97(4):1159-1168. doi:<a href=\"https:\/\/doi.org\/10.1210\/jc.2011-3362\" target=\"_blank\" rel=\"noopener nofollow\">10.1210\/jc.2011-3362<\/a><\/li>\n<li id=\"ref-2\">Nappi RE, Simoncini T. Menopause transition: a golden age to prevent cardiovascular disease. <em>Lancet Diabetes Endocrinol<\/em>. 2021;9(3):135-137. doi:<a href=\"https:\/\/doi.org\/10.1016\/S2213-8587(21)00018-8\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/S2213-8587(21)00018-8<\/a><\/li>\n<li id=\"ref-3\">Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. <em>Endocrinol Metab Clin North Am<\/em>. 2015;44(3):497-515. doi:<a href=\"https:\/\/doi.org\/10.1016\/j.ecl.2015.05.001\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/j.ecl.2015.05.001<\/a><\/li>\n<li id=\"ref-4\">El Khoudary SR, Greendale G, Crawford SL, et al. The menopause transition and women&#8217;s health at midlife: a progress report from the Study of Women&#8217;s Health Across the Nation (SWAN). <em>Menopause<\/em>. 2019;26(10):1213-1227. doi:<a href=\"https:\/\/doi.org\/10.1097\/GME.0000000000001424\" target=\"_blank\" rel=\"noopener nofollow\">10.1097\/GME.0000000000001424<\/a><\/li>\n<li id=\"ref-5\">Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition. <em>Hum Reprod Update<\/em>. 2007;13(6):559-565. doi:<a href=\"https:\/\/doi.org\/10.1093\/humupd\/dmm020\" target=\"_blank\" rel=\"noopener nofollow\">10.1093\/humupd\/dmm020<\/a><\/li>\n<li id=\"ref-6\">Davis SR, Wahlin-Jacobsen S. Testosterone in women: the clinical significance. <em>Lancet Diabetes Endocrinol<\/em>. 2015;3(12):980-992. doi:<a href=\"https:\/\/doi.org\/10.1016\/S2213-8587(15)00284-3\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/S2213-8587(15)00284-3<\/a><\/li>\n<li id=\"ref-7\">Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. <em>J Steroid Biochem Mol Biol<\/em>. 2014;142:115-120. doi:<a href=\"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.08.010\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/j.jsbmb.2013.08.010<\/a><\/li>\n<li id=\"ref-8\">Baker FC, de Zambotti M, Colrain IM, Bei B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. <em>Nat Sci Sleep<\/em>. 2018;10:73-95. doi:<a href=\"https:\/\/doi.org\/10.2147\/NSS.S125807\" target=\"_blank\" rel=\"noopener nofollow\">10.2147\/NSS.S125807<\/a><\/li>\n<li id=\"ref-9\">Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression. <em>J Womens Health<\/em>. 2019;28(2):117-134. doi:10.1089\/jwh.2018.27099.mensocrdings<\/li>\n<li id=\"ref-10\">Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology. <em>Menopause<\/em>. 2014;21(10):1063-1068. doi:<a href=\"https:\/\/doi.org\/10.1097\/GME.0000000000000329\" target=\"_blank\" rel=\"noopener nofollow\">10.1097\/GME.0000000000000329<\/a><\/li>\n<li id=\"ref-11\">Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. <em>JCI Insight<\/em>. 2019;4(5):e124865. doi:<a href=\"https:\/\/doi.org\/10.1172\/jci.insight.124865\" target=\"_blank\" rel=\"noopener nofollow\">10.1172\/jci.insight.124865<\/a><\/li>\n<li id=\"ref-12\">Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve. <em>Fertil Steril<\/em>. 2020;114(6):1151-1157. doi:<a href=\"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.09.134\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/j.fertnstert.2020.09.134<\/a><\/li>\n<li id=\"ref-13\">The 2022 Hormone Therapy Position Statement of The North American Menopause Society. <em>Menopause<\/em>. 2022;29(7):767-794. doi:<a href=\"https:\/\/doi.org\/10.1097\/GME.0000000000002028\" target=\"_blank\" rel=\"noopener nofollow\">10.1097\/GME.0000000000002028<\/a><\/li>\n<li id=\"ref-14\">Files JA, Ko MG, Pruthi S. Bioidentical hormone therapy. <em>Mayo Clin Proc<\/em>. 2011;86(7):673-680. doi:<a href=\"https:\/\/doi.org\/10.4065\/mcp.2010.0714\" target=\"_blank\" rel=\"noopener nofollow\">10.4065\/mcp.2010.0714<\/a><\/li>\n<li id=\"ref-15\">Johnson KA, Martin N, Nappi RE, et al. Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: a phase 3 RCT. <em>J Clin Endocrinol Metab<\/em>. 2023;108(8):1981-1997. doi:<a href=\"https:\/\/doi.org\/10.1210\/clinem\/dgad058\" target=\"_blank\" rel=\"noopener nofollow\">10.1210\/clinem\/dgad058<\/a><\/li>\n<li id=\"ref-16\">Daley A, Stokes-Lampard H, Thomas A, MacArthur C. Exercise for vasomotor menopausal symptoms. <em>Cochrane Database Syst Rev<\/em>. 2014;(11):CD006108. doi:<a href=\"https:\/\/doi.org\/10.1002\/14651858.CD006108.pub4\" target=\"_blank\" rel=\"noopener nofollow\">10.1002\/14651858.CD006108.pub4<\/a><\/li>\n<li id=\"ref-17\">Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. <em>Cochrane Database Syst Rev<\/em>. 2012;(9):CD007244. doi:<a href=\"https:\/\/doi.org\/10.1002\/14651858.CD007244.pub2\" target=\"_blank\" rel=\"noopener nofollow\">10.1002\/14651858.CD007244.pub2<\/a><\/li>\n<li id=\"ref-18\">Avis NE, Coeytaux RR, Iber S, Sohl S, Flatt SW. Acupuncture in menopause (AIM) study: a pragmatic randomized controlled trial. <em>Menopause<\/em>. 2016;23(6):626-637. doi:<a href=\"https:\/\/doi.org\/10.1097\/GME.0000000000000597\" target=\"_blank\" rel=\"noopener nofollow\">10.1097\/GME.0000000000000597<\/a><\/li>\n<li id=\"ref-19\">Crandall CJ, Larson J, Gourlay ML, et al. Osteoporosis screening in postmenopausal women 50 to 64 years old. <em>JAMA Intern Med<\/em>. 2020;180(8):1121-1131. doi:10.1001\/jamainternmed.2020.1007<\/li>\n<li id=\"ref-20\">El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk. <em>Circulation<\/em>. 2020;142(25):e506-e532. doi:<a href=\"https:\/\/doi.org\/10.1161\/CIR.0000000000000912\" target=\"_blank\" rel=\"noopener nofollow\">10.1161\/CIR.0000000000000912<\/a><\/li>\n<li id=\"ref-21\">Mosconi L, Berti V, Quinn C, et al. Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. <em>Neurology<\/em>. 2017;89(13):1382-1390. doi:<a href=\"https:\/\/doi.org\/10.1212\/WNL.0000000000004425\" target=\"_blank\" rel=\"noopener nofollow\">10.1212\/WNL.0000000000004425<\/a><\/li>\n<li id=\"ref-22\">Kingsberg SA, Schaffir J, Faught BM, et al. Female sexual health: barriers to optimal outcomes and a roadmap for improved patient-clinician interactions. <em>J Womens Health<\/em>. 2019;28(4):432-443. doi:<a href=\"https:\/\/doi.org\/10.1089\/jwh.2018.7352\" target=\"_blank\" rel=\"noopener nofollow\">10.1089\/jwh.2018.7352<\/a><\/li>\n<li id=\"ref-23\">Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. <em>Maturitas<\/em>. 2010;65(2):161-166. doi:<a href=\"https:\/\/doi.org\/10.1016\/j.maturitas.2009.08.003\" target=\"_blank\" rel=\"noopener nofollow\">10.1016\/j.maturitas.2009.08.003<\/a><\/li>\n<li id=\"ref-24\"><a href=\"\/blog\/category\/hormone-therapy\/\">Hormone Health: What You Need to Know<\/a><\/li>\n<li id=\"ref-25\">Protecting Bone Density as You Age<\/li>\n<li id=\"ref-26\"><a href=\"\/blog\/category\/fatigue-recovery-syndromes\/\">Sleep Optimization: Evidence-Based Strategies<\/a><\/li>\n<li id=\"ref-27\"><a href=\"\/blog\/category\/womens-health-menopause\/\">Cardiovascular Health for Women<\/a><\/li>\n<li id=\"ref-28\">A Practical Guide to Adaptogens<\/li>\n<li id=\"ref-29\"><a href=\"https:\/\/regenerated.com\/blog\/perimenopause-guide\/\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/regenerated.com\/blog\/perimenopause-guide\/<\/a>&#8220;>perimenopause symptoms, timeline, and what helps<\/a><\/li>\n<li id=\"ref-30\"><a href=\"https:\/\/regenerated.com\/blog\/hrt-for-women\/\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/regenerated.com\/blog\/hrt-for-women\/<\/a>&#8220;>HRT for women: benefits, risks, and the current evidence<\/a><\/li>\n<li id=\"ref-31\"><a href=\"https:\/\/regenerated.com\/blog\/endometriosis-treatment-options\/\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/regenerated.com\/blog\/endometriosis-treatment-options\/<\/a>&#8220;>endometriosis treatment options<\/a><\/li>\n<\/ol>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Everything you need to know about menopause, from perimenopause through postmenopause. Covers hormonal changes, symptoms, HRT, bioidentical hormones, integrative approaches, bone health, cardiovascular risk, and when to see a specialist.<\/p>\n","protected":false},"author":1,"featured_media":6293,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1010],"tags":[],"class_list":["post-5960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-womens-health-menopause"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5960"}],"version-history":[{"count":5,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5960\/revisions"}],"predecessor-version":[{"id":6950,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5960\/revisions\/6950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6293"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}